Review




Structured Review

neurobehavioral systems inc presentation software
Presentation Software, supplied by neurobehavioral systems inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/visual+stimulation+task/presentation+software/pm37347352-116-13-15
Average 90 stars, based on 1 article reviews
presentation software - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Deceptive safety? The impact of costly pain avoidance on the modulation and extinction of visceral pain-related fear
Article Snippet: All stimuli were presented in a balanced and pseudo-randomized order using Presentation® software (Neurobehavioral Systems, Albany, CA, USA) with the following constraints: no more than two consecutive repetitions of the same CS or trial type and equal numbers of each CS.

Software:

Article Title: Development and validation of an fMRI-informed EEG model of reward- related ventral striatum activation
Article Snippet: .. The excerpts were presented using Presentation software (Neurobehavioral Systems, Albany, CA) through MR-compatible headphones (50-15,000 Hz frequency response) with about 25 dB of passive gradient noise attenuation and over 20 dB active noise cancellation (Optoacoustics, Israel). ..

Article Title: Alpha and theta activity during reward anticipation are modulated by implicit expectations about sequential risk
Article Snippet: .. The task was implemented using Presentation software (Version 21.1; Neurobehavioral Systems, Inc., Berkeley, CA), and participants’ responses were recorded via a Cedrus RB-540 response device (Cedrus Corporation, San Pedro, CA). ..

Article Title: Auditory N1, N2, and MMN to Pure-Tone and Consonant–Vowel Stimuli in Developmental Dyslexia and Benign Rolandic Epilepsy: A Progressive Insight Into the Underlying Disruptive Neurophysiology
Article Snippet: .. Stimuli were binaurally presented using Presentation ® software (Neurobehavioral Systems) via closed headphones, while the participants were comfortably seated in an armchair and instructed to keep alert with their eyes open, actively listen to the auditory stimuli, and focus on a small cross in the center of a computer screen during the recording. ..

Article Title: Exploring suicidal behaviour through implicit identity and control biases: Findings from the Death-Implicit Association Test and its novel control-adaptation.
Article Snippet: .. The DIATs were conducted on computers with screens ranging from 15.6 to 17.3 in. using Presentation software (Version 20.3, Neurobehavioral Systems); completion of all D-IATs took approximately 30 min. ..

Article Title: Associations between prenatal exposure to a mixture of lead, mercury and polychlorinated biphenyls and executive function in Inuit adolescents.
Article Snippet: .. The experiment was performed using the Presentation® (Neurobehavioral Systems, 2012) software. ..

Article Title: Supporting Information for Differential neural mechanisms underlie cortical gating of visual spatial attention mediated by alpha-band oscillations
Article Snippet: .. Visual stimuli were presented on a laptop computer placed approximately 80 cm away from the subject’s eyes using Presentation software (Neurobehavioral Systems, Inc.). ..

Article Title: Neural correlates of false belief understanding in 33- to 36-month-old infants.
Article Snippet: .. Presentation software was used to deliver the stimulus (Neurobehavioral Systems). .. The electroencephalogram (EEG) was recorded with Cz reference from 33 active electrodes (ActiCap System, Brain Products, Gilching, Germany) placed on standard positions of the extended international 10–20 System.



Similar Products

90
Scherf GmbH visual stimulation task
Visual Stimulation Task, supplied by Scherf GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/visual+stimulation+task/visual+cortex/pmc06865463-286-1-13
Average 90 stars, based on 1 article reviews
visual stimulation task - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
MathWorks Inc dynamic visual stimulation task
Patients with fibromyalgia report increased affective unpleasantness in response to visual <t>stimulation.</t> (A) A dynamic visual stimulus was presented to individuals with fibromyalgia and healthy controls wherein participants viewed a 3-minute movie clip of alternating 20-second blocks of a flashing (8 Hz) blue-yellow annulus checkerboard (left panel) and a static fixation cross (right panel). The checkerboard was presented in increasing illumination levels, ranging from 4.5 to 78 lux. (B) Participants rated the unpleasantness evoked by the visual stimulus at each illumination level (left panel), and the overall unpleasantness of the entire visual task (right panel). FM = patients with fibromyalgia; HC = healthy control participants. *Significant pairwise comparisons.
Dynamic Visual Stimulation Task, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/visual+stimulation+task/pmc04988086-38-4-10
Average 90 stars, based on 1 article reviews
dynamic visual stimulation task - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Patients with fibromyalgia report increased affective unpleasantness in response to visual stimulation. (A) A dynamic visual stimulus was presented to individuals with fibromyalgia and healthy controls wherein participants viewed a 3-minute movie clip of alternating 20-second blocks of a flashing (8 Hz) blue-yellow annulus checkerboard (left panel) and a static fixation cross (right panel). The checkerboard was presented in increasing illumination levels, ranging from 4.5 to 78 lux. (B) Participants rated the unpleasantness evoked by the visual stimulus at each illumination level (left panel), and the overall unpleasantness of the entire visual task (right panel). FM = patients with fibromyalgia; HC = healthy control participants. *Significant pairwise comparisons.

Journal: Pain

Article Title: Pharmacologic attenuation of cross-modal sensory augmentation within the chronic pain insula

doi: 10.1097/j.pain.0000000000000593

Figure Lengend Snippet: Patients with fibromyalgia report increased affective unpleasantness in response to visual stimulation. (A) A dynamic visual stimulus was presented to individuals with fibromyalgia and healthy controls wherein participants viewed a 3-minute movie clip of alternating 20-second blocks of a flashing (8 Hz) blue-yellow annulus checkerboard (left panel) and a static fixation cross (right panel). The checkerboard was presented in increasing illumination levels, ranging from 4.5 to 78 lux. (B) Participants rated the unpleasantness evoked by the visual stimulus at each illumination level (left panel), and the overall unpleasantness of the entire visual task (right panel). FM = patients with fibromyalgia; HC = healthy control participants. *Significant pairwise comparisons.

Article Snippet: Participants underwent a 3-minute dynamic visual stimulation task developed in MATLAB (Mathworks, Natick, MA) that consisted of alternating 20-second blocks of a flashing (8 Hz frequency) blue-yellow annulus checkerboard and a static fixation cross (Fig. A).

Techniques: Control

Journal: Pain

Article Title: Pharmacologic attenuation of cross-modal sensory augmentation within the chronic pain insula

doi: 10.1097/j.pain.0000000000000593

Figure Lengend Snippet: Age, clinical pain, and responses to experimental sensory stimulation.

Article Snippet: Participants underwent a 3-minute dynamic visual stimulation task developed in MATLAB (Mathworks, Natick, MA) that consisted of alternating 20-second blocks of a flashing (8 Hz frequency) blue-yellow annulus checkerboard and a static fixation cross (Fig. A).

Techniques:

Increased brain activation in response to aversive visual stimulation is associated with clinical pain intensity in fibromyalgia. (A) Individuals with fibromyalgia (FM) displayed greater functional magnetic resonance imaging blood–oxygen-level-dependent (BOLD) activations in right anterior insula than healthy controls (HC) during the presentation of a dynamic visual stressor. (B) Within the FM group, anterior insular activation was positively correlated with the degree of clinical pain measured using a 100-mm visual analog scale (VAS). IC, insular cortex.

Journal: Pain

Article Title: Pharmacologic attenuation of cross-modal sensory augmentation within the chronic pain insula

doi: 10.1097/j.pain.0000000000000593

Figure Lengend Snippet: Increased brain activation in response to aversive visual stimulation is associated with clinical pain intensity in fibromyalgia. (A) Individuals with fibromyalgia (FM) displayed greater functional magnetic resonance imaging blood–oxygen-level-dependent (BOLD) activations in right anterior insula than healthy controls (HC) during the presentation of a dynamic visual stressor. (B) Within the FM group, anterior insular activation was positively correlated with the degree of clinical pain measured using a 100-mm visual analog scale (VAS). IC, insular cortex.

Article Snippet: Participants underwent a 3-minute dynamic visual stimulation task developed in MATLAB (Mathworks, Natick, MA) that consisted of alternating 20-second blocks of a flashing (8 Hz frequency) blue-yellow annulus checkerboard and a static fixation cross (Fig. A).

Techniques: Activation Assay, Functional Assay, Magnetic Resonance Imaging

Specific attenuation of insular response to aversive visual stimulation by pregabalin. (A) A subset of 17 patients with fibromyalgia underwent aversive visual stimulation during functional magnetic resonance imaging (fMRI) both before and after pregabalin and placebo administration. After the pregabalin period, a significant reduction in bilateral insular blood–oxygen-level-dependent (BOLD) activation in response to the visual stimulus was observed (left). No reductions in insular activation were observed after placebo treatment (right). Lines denote fMRI BOLD values for each participant (pre and post drug or placebo). Blue lines represent individuals with a decrease in BOLD activity, whereas red lines denote increases in BOLD activity. (B) A direct contrast between pregabalin and placebo periods shows decreased visual stimulus-evoked BOLD response in the right insula after pregabalin treatment.

Journal: Pain

Article Title: Pharmacologic attenuation of cross-modal sensory augmentation within the chronic pain insula

doi: 10.1097/j.pain.0000000000000593

Figure Lengend Snippet: Specific attenuation of insular response to aversive visual stimulation by pregabalin. (A) A subset of 17 patients with fibromyalgia underwent aversive visual stimulation during functional magnetic resonance imaging (fMRI) both before and after pregabalin and placebo administration. After the pregabalin period, a significant reduction in bilateral insular blood–oxygen-level-dependent (BOLD) activation in response to the visual stimulus was observed (left). No reductions in insular activation were observed after placebo treatment (right). Lines denote fMRI BOLD values for each participant (pre and post drug or placebo). Blue lines represent individuals with a decrease in BOLD activity, whereas red lines denote increases in BOLD activity. (B) A direct contrast between pregabalin and placebo periods shows decreased visual stimulus-evoked BOLD response in the right insula after pregabalin treatment.

Article Snippet: Participants underwent a 3-minute dynamic visual stimulation task developed in MATLAB (Mathworks, Natick, MA) that consisted of alternating 20-second blocks of a flashing (8 Hz frequency) blue-yellow annulus checkerboard and a static fixation cross (Fig. A).

Techniques: Functional Assay, Magnetic Resonance Imaging, Activation Assay, Activity Assay